Neurodegenerative changes initiated by presynaptic dysfunction
暂无分享,去创建一个
[1] C. Choong,et al. Neurodegenerative changes initiated by presynaptic dysfunction , 2013, Translational Neurodegeneration.
[2] A. Kawanami,et al. Accumulation of α-Synuclein Triggered by Presynaptic Dysfunction , 2012, The Journal of Neuroscience.
[3] H. Mochizuki,et al. α-Synuclein and Neuronal Cell Death , 2012, Molecular Neurobiology.
[4] K. Jellinger. Potential role of α‐synuclein in neurodegeneration: studies in a rat animal model , 2012, Journal of neurochemistry.
[5] E. Masliah,et al. Multiple system atrophy: a clinical and neuropathological perspective , 2011, Trends in Neurosciences.
[6] K. Inokuchi,et al. A Single Amino Acid Mutation in SNAP-25 Induces Anxiety-Related Behavior in Mouse , 2011, PloS one.
[7] E. Neher,et al. Protein scaffolds in the coupling of synaptic exocytosis and endocytosis , 2011, Nature Reviews Neuroscience.
[8] T. Südhof,et al. α-Synuclein Promotes SNARE-Complex Assembly in Vivo and in Vitro , 2010, Science.
[9] B. Ghetti,et al. SNARE protein redistribution and synaptic failure in a transgenic mouse model of Parkinson's disease. , 2010, Brain : a journal of neurology.
[10] B. Davletov,et al. α‐Synuclein sequesters arachidonic acid to modulate SNARE‐mediated exocytosis , 2010, EMBO reports.
[11] W. Schulz-Schaeffer. The synaptic pathology of α-synuclein aggregation in dementia with Lewy bodies, Parkinson’s disease and Parkinson’s disease dementia , 2010, Acta Neuropathologica.
[12] E. Masliah,et al. A Pathologic Cascade Leading to Synaptic Dysfunction in α-Synuclein-Induced Neurodegeneration , 2010, The Journal of Neuroscience.
[13] R. Nicoll,et al. Increased Expression of α-Synuclein Reduces Neurotransmitter Release by Inhibiting Synaptic Vesicle Reclustering after Endocytosis , 2010, Neuron.
[14] R. Burke,et al. Mutant LRRK2R1441G BAC transgenic mice recapitulate cardinal features of Parkinson's disease , 2009, Nature Neuroscience.
[15] Ole Isacson,et al. Dynamic Changes in Presynaptic and Axonal Transport Proteins Combined with Striatal Neuroinflammation Precede Dopaminergic Neuronal Loss in a Rat Model of AAV α-Synucleinopathy , 2009, The Journal of Neuroscience.
[16] M. Cookson. α-Synuclein and neuronal cell death , 2009, Molecular Neurodegeneration.
[17] R. Nussbaum,et al. Proteomics Analysis Identifies Phosphorylation-dependent α-Synuclein Protein Interactions *S , 2008, Molecular & Cellular Proteomics.
[18] T. Iwatsubo,et al. A systematic RNAi screen reveals involvement of endocytic pathway in neuronal dysfunction in alpha-synuclein transgenic C. elegans. , 2008, Human molecular genetics.
[19] Satoshi Orimo,et al. Axonal α-synuclein aggregates herald centripetal degeneration of cardiac sympathetic nerve in Parkinson's disease , 2008 .
[20] Mari Yoshida,et al. Multiple system atrophy: α‐synuclein and neuronal degeneration , 2007, Neuropathology : official journal of the Japanese Society of Neuropathology.
[21] H. Tanila,et al. Role of α-synuclein in synaptic glutamate release , 2007, Neurobiology of Disease.
[22] Michael L. Kramer,et al. Presynaptic α-Synuclein Aggregates, Not Lewy Bodies, Cause Neurodegeneration in Dementia with Lewy Bodies , 2007, The Journal of Neuroscience.
[23] Leonidas Stefanis,et al. α-Synuclein Overexpression in PC12 and Chromaffin Cells Impairs Catecholamine Release by Interfering with a Late Step in Exocytosis , 2006, The Journal of Neuroscience.
[24] Thomas C. Südhof,et al. α-Synuclein Cooperates with CSPα in Preventing Neurodegeneration , 2005, Cell.
[25] L. F. Ciufo,et al. Regulation of exocytosis by protein kinase C. , 2005, Biochemical Society transactions.
[26] R. Palmiter,et al. Dopamine Modulates Release from Corticostriatal Terminals , 2004, The Journal of Neuroscience.
[27] T. Iwatsubo,et al. Accumulation of Phosphorylated α‐Synuclein in Aging Human Brain , 2003 .
[28] Hideo Fujiwara,et al. Misfolded proteinase K-resistant hyperphosphorylated alpha-synuclein in aged transgenic mice with locomotor deterioration and in human alpha-synucleinopathies. , 2002, The Journal of clinical investigation.
[29] E. Neher,et al. Protein Kinase C-Dependent Phosphorylation of Synaptosome-Associated Protein of 25 kDa at Ser187 Potentiates Vesicle Recruitment , 2002, The Journal of Neuroscience.
[30] Richard Paylor,et al. Synaptic Vesicle Depletion Correlates with Attenuated Synaptic Responses to Prolonged Repetitive Stimulation in Mice Lacking α-Synuclein , 2002, The Journal of Neuroscience.
[31] M. Itakura,et al. Protein kinase C‐mediated translocation of secretory vesicles to plasma membrane and enhancement of neurotransmitter release from PC12 cells , 2002, The European journal of neuroscience.
[32] J Q Trojanowski,et al. Synucleinopathies: clinical and pathological implications. , 2001, Archives of neurology.
[33] G. Augustine,et al. A Conserved Clathrin Assembly Motif Essential for Synaptic Vesicle Endocytosis , 2000, The Journal of Neuroscience.
[34] M. Goedert,et al. The α‐Synucleinopathies: Parkinson's Disease, Dementia with Lewy Bodies, and Multiple System Atrophy , 2000 .
[35] M. Sekiguchi,et al. Two distinct mechanisms underlie the stimulation of neurotransmitter release by phorbol esters in clonal rat pheochromocytoma PC12 cells. , 2000, Journal of biochemistry.
[36] J. Trojanowski,et al. Synucleins Are Developmentally Expressed, and α-Synuclein Regulates the Size of the Presynaptic Vesicular Pool in Primary Hippocampal Neurons , 2000, The Journal of Neuroscience.
[37] H. Majewski,et al. Protein kinase C: a physiological mediator of enhanced transmitter output , 1998, Progress in Neurobiology.
[38] A. Omori,et al. Phosphorylation of 25-kDa Synaptosome-associated Protein , 1996, The Journal of Biological Chemistry.
[39] Akihiko Iwai,et al. The precursor protein of non-Aβ component of Alzheimer's disease amyloid is a presynaptic protein of the central nervous system , 1995, Neuron.
[40] R. Scheller,et al. Synuclein: a neuron-specific protein localized to the nucleus and presynaptic nerve terminal , 1988, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[41] T. Südhof,et al. CSPα promotes SNARE-complex assembly by chaperoning SNAP-25 during synaptic activity , 2011, Nature Cell Biology.
[42] R. Burgoyne,et al. Chaperoning the SNAREs: a role in preventing neurodegeneration? , 2010, Nature Cell Biology.
[43] Junchao Tong,et al. Brain alpha-synuclein accumulation in multiple system atrophy, Parkinson's disease and progressive supranuclear palsy: a comparative investigation. , 2010, Brain : a journal of neurology.
[44] A. Kakita,et al. Axonal alpha-synuclein aggregates herald centripetal degeneration of cardiac sympathetic nerve in Parkinson's disease. , 2008, Brain : a journal of neurology.
[45] Michael L. Kramer,et al. Presynaptic alpha-synuclein aggregates, not Lewy bodies, cause neurodegeneration in dementia with Lewy bodies. , 2007, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[46] H. Tanila,et al. Role of alpha-synuclein in synaptic glutamate release. , 2007, Neurobiology of disease.
[47] T. Südhof,et al. Alpha-synuclein cooperates with CSPalpha in preventing neurodegeneration. , 2005, Cell.
[48] J. Wickens,et al. Chapter IV Structural and functional interactions in the striatum at the receptor level , 2005 .
[49] T. Sudhof,et al. The synaptic vesicle cycle. , 2004, Annual review of neuroscience.
[50] Hideo Fujiwara,et al. Accumulation of phosphorylated alpha-synuclein in aging human brain. , 2003, Journal of neuropathology and experimental neurology.
[51] J. Trojanowski,et al. Misfolded proteinase K-resistant hyperphosphorylated alpha-synuclein in aged transgenic mice with locomotor deterioration and in human alpha-synucleinopathies. , 2002, The Journal of clinical investigation.
[52] M. Goedert,et al. The alpha-synucleinopathies: Parkinson's disease, dementia with Lewy bodies, and multiple system atrophy. , 2000, Annals of the New York Academy of Sciences.
[53] A. Lee. Biomembranes : a multi-volume treatise , 1995 .